Bacteria Discovered to Break Down Chemotherapy Drugs

One of the most important problems encountered in cancer treatment is resistance to chemotherapy drugs. In recent years, various factors causing drug resistance in cancer have been investigated. In September 2017, Science published a study showing that bacteria inside pancreatic cancer cells inactivate one of the few chemotherapy drugs shown to work in this cancer, gemcitabine , by breaking it down.
The study discovered that a bacterium called M. hyorhinis is present inside cancer cells and breaks down the drug gemcitabine. To do this, the bacterium uses an enzyme called cytidine deaminase (cytidine deaminase).
- Researchers then examined whether this enzyme was also present in other bacterial species. Among 2674 bacteria that can live in humans, the enzyme was identified in 11 percent.
- 113 pancreatic cancer patients provided tissue samples that were investigated for these bacteria. Bacteria producing the enzyme that breaks down gemcitabine were identified in 86 patients. These bacterial types generally include species such as E. coli and salmonella.
- In addition, these types of bacteria were injected into laboratory animals to understand the role of bacteria in tumor resistance to drugs. In mice given gemcitabine and an antibiotic, the bacteria were effectively eliminated and the tumor shrank. In mice given gemcitabine alone, the tumor grew rapidly.
So What Does This Study Mean for Us?
- An important mechanism of drug resistance has been clarified. In cancer, drug resistance is caused not only by the tumor microenvironment but also by bacteria within the cancer’s internal structure.
- This study may explain why gemcitabine ceases to be effective after some time on treatment in most patients with pancreatic cancer.
- In the future, cancer treatments may be planned according to the bacteria a patient carries.
- This study was conducted in laboratory cell cultures and animal models. It needs to be confirmed by further studies in humans.
- Further studies may also investigate antibiotic use alongside standard cancer treatments. However, it must be emphasized that long-term antibiotic use may cause antibiotic-resistant bacteria to emerge and also reduces the effectiveness of cancer immunotherapies .
- Developing drugs that inhibit the activity of the enzymes enabling bacteria to break down the drug is a better solution. In that case, antibiotics would not be needed and the bacteria would not develop resistance.
- The same research group is analyzing how another chemotherapy drug, oxaliplatin, is broken down by bacteria.
Article Image: Bacteria (shown in green) are visible inside pancreatic cancer cells.
Sources
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Science - 15 Sep 2017
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.